Cephalosporin resistant Neisseria gonorrhoeae: Time to consider gentamicin?

Sexually Transmitted Infections

Volumn 88, Issue 1, 2012, Pages 6-8

  Ross, J D C ^a   Lewis, D A ^b,c  

^a UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^b NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

^c UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CEFIXIME; CEFTRIAXONE; CEPHALOSPORIN; DOXYCYCLINE; GEMIFLOXACIN; GENTAMICIN; MACROLIDE; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; CHLAMYDIA TRACHOMATIS; COMBINATION CHEMOTHERAPY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG COST; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG EXCRETION; EDITORIAL; GONORRHEA; HUMAN; KIDNEY FUNCTION; LOW DRUG DOSE; MINIMUM INHIBITORY CONCENTRATION; NEISSERIA GONORRHOEAE; OTOTOXICITY; PRIORITY JOURNAL; SIDE EFFECT; SINGLE DRUG DOSE; TREATMENT FAILURE;

ANTI-BACTERIAL AGENTS; CEPHALOSPORIN RESISTANCE; DRUG SUBSTITUTION; GENTAMICINS; GONORRHEA; HUMANS; NEISSERIA GONORRHOEAE;

EID: 84855881092     PISSN: 13684973     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/sextrans-2011-050362     Document Type: Editorial

References (25)

1. Lewis DA. The gonococcus fights back: is this time a knock out? Sex Transm Infect 2010;86:415-21.
2. Ito M, Yasuda M, Yokoi S, et al. Remarkable increase in central Japan in 2001-2002 of Neisseria gonorrhoeae isolates with decreased susceptibility to penicillin, tetracycline, oral cephalosporins, and fluoroquinolones. Antimicrob Agents Chemother 2004;48:3185-7. (Pubitemid 38989201)
3. Deguchi T, Yasuda M, Yokoi S, et al. Treatment of uncomplicated gonococcal urethritis by double-dosing of 200 mg cefixime at a 6-h interval. J Infect Chemother 2003;9:35-9. (Pubitemid 36504368)
4. Lo JY, Ho KM, Leung AO, et al. Ceftibuten resistance and treatment failure of Neisseria gonorrhoeae infection. Antimicrob Agents Chemother 2008;52:3564-7.
5. Chisholm SA, Mouton JW, Lewis DA, et al. Cephalosporin MIC creep among gonococci: time for a pharmacodynamic rethink? J Antimicrob Chemother 2010;65:2141-8.
6. Tapsall JW, Ndowa F, Lewis DA, et al. Meeting the public health challenge of multidrug- and extensively drug-resistant Neisseria gonorrhoeae. Expert Rev Anti Infect Ther 2009;7:821-34.
7. Ohnishi M, Golparian D, Shimuta K, et al. Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea? Detailed characterization of the first strain with high-level resistance to ceftriaxone. Antimicrob Agents Chemother 2011;55:3538-45.
8. BASHH Clinical Effectiveness Group. UK national guideline for the management of gonorrhoea in adults. 2011. Available from: http://www.bashh.org/ guidelines (accessed 15 Dec 2011).
9. Centers for Disease Control. Sexually transmitted diseases treatment guidelines. 2010. Available from: http://www.cdc gov/std/treatment/2010/ gonococcal-infections htm (accessed 15 Dec 2011).
10. Sexual Health Society of Victoria. National management guidelines for sexually transmitted infections. 2006. Available from: http://mshc.org.au/ Portals/6/NMGFSTI.pdf (accessed 15 Dec 2011).
11. Vakulenko SB, Mobashery S. Versatility of aminoglycosides and prospects for their future. Clin Microbiol Rev 2003;16:430-50. (Pubitemid 36871315)
12. Johnson SR, Morse SA. Antibiotic resistance in Neisseria gonorrhoeae: genetics and mechanisms of resistance. Sex Transm Dis 1988;15:217-24. (Pubitemid 19029045)
13. Daly CC, Hoffman I, Hobbs M, et al. Development of an antimicrobial susceptibility surveillance system for Neisseria gonorrhoeae in Malawi: comparison of methods. J Clin Microbiol 1997;35:2985-8. (Pubitemid 27452451)
14. Pandhi RK, Jayant D, Gupta A, et al. Efficacy of gentamicin in gonococcal urethritis. Sex Transm Dis 1989;10:48-50. (Pubitemid 20184259)
15. Tan NJ, Rajan VS, Pang R, et al. Gentamicin in the treatment of infections due to penicillinase-producing gonococci. Br J Vener Dis 1980;56:394-6. (Pubitemid 11161282)
16. Bowie W, Ronald AR, Krywulak W, et al. Gentamicin in the treatment of gonorrhoea in females. Br J Vener Dis 1974;50:208-11.
17. Hantschke D, Strauss P, Linzenmeier G, et al. Treatment of gonorrhoea with single injections of gentamicin. Br J Vener Dis 1973;49:62-4.
18. Siboulet A. Results of the minute treatment of gonorrhoea in 26,339 cases. Postgrad Med J 1972;48(Suppl 1):65-70.
19. Felarca AB, Laqui EM, Ibarra LM. Gentamicin in gonococcal urethritis of Filipino males: dosage and response. J Infect Dis 1971;124:S287-92.
20. Yoon JY, Kim YT, Kim JH. Treatment of uncomplicated male gonococcal urethritis. Kanamycin vs. gentamicin. Korean J Dermatol 1988;26:184-8.
21. Hira SK, Attili VR, Kamanga J, et al. Efficacy of gentamicin and kanamycin in the treatment of uncomplicated gonococcal urethritis in Zambia. Sex Transm Dis 1985;12:52-4. (Pubitemid 15143211)
22. Pareek SS, Chowdhury MN. Comparative study between gentamicin and spectinomycin in the treatment of infections due to penicillin-resistant gonococci. Curr Ther Res Clin E 1981;30:177-80. (Pubitemid 11095538)
23. Brown LB, Krysiak R, Kamanga G, et al. Neisseria gonorrhoeae antimicrobial susceptibility in Lilongwe, Malawi, 2007. Sex Transm Dis 2010;37:169-72.
24. Chisholm SA, Quaye N, Cole MJ, et al. An evaluation of gentamicin susceptibility of Neisseria gonorrhoeae isolates in Europe. J Antimicrob Chemother 2011;66:592-5.
25. Qian Y, Guan MX. Interaction of aminoglycosides with human mitochondrial 12S rRNA carrying the deafness-associated mutation. Antimicrob Agents Chemother 2009;53:4612-18.